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Abstract 
Background: Obstructive sleep apnoea (OSA) is increasingly common in bariatric patients 
undergoing sedation during elective surgery. However, it has not been established how 
significant a contributor it is to peri-operative respiratory complications and mortality. We 
sought to pre-operatively identify OSA in bariatric patients and record peri-operative 
complications during and after bariatric surgery. 
Methods: Data were collected and analysed from June 2014 to March 2017 for 410 
bariatric surgery patients referred to the sleep laboratory for pre-operative screening and 
treatment of OSA. The STOP-Bang questionnaire, Epworth Sleepiness Scale (ESS) and 
nocturnal pulse oximetry were recorded and treatment was allocated with continuous 
positive airway pressure (CPAP). Peri-operative complications and mortality were the 
primary outcome measures for patients receiving CPAP treatment for OSA, with patients 
who did not require CPAP used as control. The mean follow-up time for all patients was 433 
days and 732 days for the patients who had undergone bariatric surgery. The two groups 
were compared with Chi square test and unpaired two-tailed t-test.  
Results: OSA was present in any form in 70% of the screened patients. 40% of patients 
involved in the study received CPAP treatment. Patients receiving CPAP treatment [49.5 
(11.3) years old, 61% female, 50.3 (8.5) kg/m2] were older, had a lower percentage of 
females and had a higher BMI than those not receiving CPAP [44.9 (12.0), 81% female, 46.6 
(7.7)]. No significant differences were observed between patients on CPAP and those not 
on CPAP, there was no significant difference in hospital stay or rate of respiratory 
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complications. Out of 53 patients who had undergone bariatric surgery at the cut-off date, 
only 1 had suffered a respiratory complication. 
Conclusion: Bariatric patients who are screened pre-operatively for OSA and treated 
according to guidelines have no increased risk of respiratory complications compared to 
patients without OSA.   
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Introduction 
The rate of obesity in the UK is one of the highest in the world (1). As of 2013, 24% of men 
and 25% of women in the UK are classified as obese, with 3% classified as type III obese 
(previously known as “morbid obesity” with a body mass index (BMI) above 40 kg/m2) (2). 
Obesity is linked to several respiratory conditions such as pneumonia, asthma, pulmonary 
embolism and obstructive sleep apnoea (OSA) (3). However, despite the increasing 
prevalence of obesity, up to 90% of OSA remains undiagnosed (4): 4% of middle-aged men 
and 2% of middle-aged women in the UK suffer from sleep apnoea (5), but severe OSA 
occurs in 10-20% of patients with a BMI above 35 kg/m2 (6). OSA and obesity are significant 
contributors to cardiovascular and metabolic morbidity and mortality, associated with 
diabetes mellitus, ischaemic heart disease, hypertension and depression (5, 6). 
 
In OSA, transient hypoxias induced by upper airway occlusion in sleep activate the 
sympathetic nervous system, increase intra-thoracic pressure swings and cause arousal 
from sleep (5). Heart rate increases and sleep is fragmented, the sleep quality decreases 
(7), causing excessive daytime sleepiness, as well as impaired cognitive function, eventually 
leading to an impaired quality of life (5). OSA is diagnosed by experts with the help of a 
sleep study (polysomnography) in conjunction with a subjective increase in daytime 
sleepiness, assessed with the aid of an Epworth Sleepiness Scale (ESS) questionnaire (5). 
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Continuous positive airway pressure (CPAP) is currently the best available treatment for 
moderate to severe OSA, effective to avoid upper airway collapse, inflate the chest and 
diminish work fo breathing and neural respiratory drive (5, 8). In the context of surgery and 
anaesthetics, obesity and OSA are associated with a greater incidence in complications both 
peri-and post-operatively, leading to longer in-hospital stays and putting additional strain 
on healthcare providers (9). Obesity itself is not necessarily linked to increased risk of 
pulmonary complications pre- or post-operatively, even in the morbidly obese (10), 
however, in conjunction with OSA this is different (11). Patients with OSA are more than 
twice as likely to develop post-operative desaturations, cardiac complications, adult 
respiratory distress syndrome (ARDS), respiratory failure, aspiration pneumonia and other 
problems that require admission to intensive care (9, 11). Frequent and extended 
desaturations also predispose patients towards opioid-induced respiratory depression due 
to hypoxaemia and hypercapnia (6). However, the risk of these complications is potentially 
reduced if OSA is identified pre-operatively and treated with CPAP (4, 6, 9, 11).  
 
We hypothesize that long-term and peri-operative complication rates are low in bariatric 
patients who are screened for OSA and, if required, treated accordingly. For this purpose, 
we identified peri- and post-operative mortality with long-term follow up, as well as 
complication rate and length of hospital stay in all screened bariatric patients and 
compared the occurrence of complications between patients with moderate-severe OSA 
with those who had mild OSA or no sleep-disordered breathing. 
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Patients and Methods 
Retrospective data of patients referred to the Lane Fox Unit (respiratory high dependency 
unit, St. Thomas’ Hospital, London, UK) and the Sleep Disorders Centre (Guy’s Hospital, 
London, UK) for assessment of sleep-disordered breathing in conjunction with bariatric 
surgery were analysed. The study was registered as a service review and approved by the 
local clinical governance board (registration number: GSTT-2017-6952). Cases were 
included between 12 June 2014 and 9 March 2017. 
Variables recorded included age (years), gender (male and female), height (m), weight at 
time of sleep study (kg), BMI (kg/m2), neck circumference, waist circumference, 
comorbidities, medication, surgery date, surgery type, intra-operative complications, post-
operative complications, length of post-operative hospital stay (days), ward vs ITU stay, 
post-operative weight at last follow up (kg), post-operative BMI at last follow up (kg/m2), 
weight loss over the follow up period (kg/year); it was recorded whether patients were 
prescribed CPAP, the respective CPAP pressure (in cmH2O), annual CPAP compliance (% of 
nights used), average nightly CPAP use (in hours), Epworth Sleepiness Scale (ESS, points) 
and Hospital Anxiety and Depression Scale (HADS, points), as well as the results of the 
nocturnal pulse oximetry data. 
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Questionnaires 
Patients scheduled to undergo bariatric surgery at Guy’s and St. Thomas’ NHS Foundation 
Trust, London, UK were screened pre-operatively with the STOP-BANG questionnaire. 
STOP-BANG is an acronym for snoring (significantly loud), tired (excessive daytime 
sleepiness), observed apnoea (others seeing the patient choking during sleep), [blood] 
pressure (current or treated hypertension), BMI (>35 kg/m2), age (>50 years), neck 
circumference (>40cm) and gender (male). Each parameter is graded ‘0’ (for “no” answers) 
and ‘1’ (for “yes” answers) (12).  A score >4 represented a risk of OSA and indicated referral 
to the Sleep Disorders Centre for more extensive investigation. 
The Epworth Sleepiness scale was recorded; it asks patients to rate the probability of falling 
asleep during eight activities of daily living on a scale of “0” to “3”, with higher scores (>10) 
indicating daytime sleepiness (13). 
The HADS is a scoring tool to assess patient’s levels of anxiety and depression. There are 14 
statements to score from “0” to “3”, seven about anxiety and seven about depression. The 
questions deliberately avoid asking about sleep because changes in sleep may be symptoms 
of these disorders (14). This scale can be used in conjunction with the ESS (10). A score 
<9/21 on either questionnaire or a total score <18/42 points is deemed normal. 
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Nocturnal Pulse Oximetry 
Patients recorded two nights of pulse oximetry at home using a Pulsox 300i (Konica Minolta 
sensing Inc, Hachioji, Tokyo, Japan). The data recorded and calculated included: 
• Mean pulse rate (min-1) 
• Number of pulse rises >6 beats per minute [“pulse rises”] (h-1) 
• Mean peripheral capillary oxygen saturation (SpO2, %) 
• Nadir peripheral capillary oxygen saturation (SpO2, %) 
• 4% and 3% oxygen desaturation index (ODI; h-1) 
• Time spent with SpO2 <90% (% of total time recorded) 
The results were further assessed by an expert sleep technician and scored by a consultant. 
OSA was defined by the number of desaturations a patient experienced per hour of sleep; 
the 4% ODI. A 4% ODI <5 events/hour was considered normal; 5-15 events/hour was mild, 
15-30 events events/hour was moderate and >30 events/hour was considered severe OSA 
(9). Possible coexisting obesity hypoventilation syndrome (OHS) was indicated by prolonged 
periods (>10% of the recorded time) of hypoxia (SpO2 <90%) during sleep. Patients were 
assigned a value from 1-5 for the severity of their OSA: 
• “1” – if no OSA present, 
• “2” – if mild OSA present, 
• “3” – if moderate OSA present, 
• “4” – if severe OSA present, 
• “5” – if patients had OSA, potentially combined with OHS 
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Recommended treatments were assigned a value from 1-5: 
• “1” – no further action necessary 
• “2” – recommendation of a mandibular advancement device if symptomatic 
• “3” – recommended extubation onto CPAP 
• “4” – peri-operative CPAP  
• “5” – referral for inpatient assessment to investigate the potential presence of OHS  
 
Statistical analysis 
Statistical analysis was performed using the Statistical Package for the Social Sciences (SPSS, 
IBM, Chicago, IL/USA) version 24.0. Categorical variables are summarised using 
percentages. A Shapiro-Wilk with Lilliefors Significance correction test was used to 
determine whether continuous variables were normally or non-normally distributed. 
Normally-distributed continuous variables are cited as “mean (standard deviation)” and 
compared using an unpaired t-test. Non-normally distributed continuous variables are cited 
as “median [interquartile range; IQR]” and compared using a Mann-Whitney test. 
Categorical variables were compared with a Chi-square test. A Pearson correlation test was 
used to compare independent and dependent variables; a Spearman correlation test was 
used to compare non-normally distributed data. A p value of <0.05 was deemed statistically 
significant. 
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Results 
Demographics 
410 patients awaiting bariatric surgery were studied, the majority were female, middle 
aged and obese [74% female (302:108), age 46.9 (11.9) years, weight 134.5 (27.5) kg, BMI 
48.1 (8.2) kg/m2, waist circumference of 136.7 (16.7) cm, neck circumference 43.6 (4.5) 
cm]. Four patients were excluded from the analysis because they had insufficient or 
unobtainable sleep results. The average of patients was not excessively sleepy, but were 
considerably susceptible to depression and/or anxiety [ESS 8.0 (5.0) points, total HADS 17.7 
(7.3) points]. Most patients (85.9%, n = 352) had a BMI >40 kg/m2, 12.4% (n = 51) had a BMI 
between 35-40 kg/m2 and 1.7% (n = 7) patients had a BMI between 30-35; 34.2% (n = 140) 
of the patients were “super obese” with a BMI ≥50 kg/m2; the highest BMI was 88.9 kg/m2. 
 
Sleep disordered breathing  
Nocturnal pulse oximetry data revealed mild-moderate OSA for the total cohort [4% ODI of 
15.4 (17.3) h-1, 3% ODI of 20.1 (19.6) h-1, mean SpO2 of 94.1 (3.6) %, a nadir SpO2 of 75.9 
(10.0) %, mean pulse rise index of 34.0 (18.6) h-1, and a time below SpO2 of 90% of 8.0 
(14.2) % of the sleep study)]. 285 out of 410 patients (70%) had at least some degree of 
OSA, while 125 (30%) had no significant degree of OSA. Of those with any degree of OSA, 
127 (31% of total patients) were mild, 82 (20% of total patients) were moderate, 57 (14% of 
total patients) had severe OSA and 19 (5%) had OSA with potentially combined OHS.  
Average follow-up time post-pulse oximetry was 432.9 (241.9) days. 
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Male vs female groups 
When comparing male with female patients, the male group was slightly older but of similar 
BMI, both groups had a similar sleep and mental health symptom score (ESS, HADS) and 
heart rate; there were about 3 times as many women as men in this cohort. There was no 
significant difference in length of hospital stay, with all but 2 patients admitted to a ward 
post-operatively; the 2 patients admitted to ICU were female. Men were on average 
heavier and had more severe sleep-disordered breathing, as indicated by the 
mean/minimum SpO2, the ODI and the percentage of the night with an SpO2 <90%, as well 
as the pulse rise index as an indicator of arousals; men were 20.3% more likely (85% of 
male patients compared to 64.7% of female patients) to require treatment 
recommendation like MAD, CPAP or referral for further respiratory assessment (Table 1). 
 
 Male Female p-value 
Age (years) 49.46 (12.1); n = 108 45.9 (11.7); n = 302 0.008 
Weight (kg) 153.4 (29.0); n = 108 127.7 (23.6); n = 301 <0.001 
BMI (kg x m-2) 49.35 (8.8); n = 108 47.6 (8.0); n = 302 0.055 
Length of stay (days) 2.2 (1.3); n = 5 2.5 (1.1); n = 28 0.556 
HADS (out of 42 points) 20.8 (6.6); n = 9 16.1 (7.3); n = 17 0.124 
Mean heart rate (min-1) 71.0 (10.1); n = 103 73.8 (9.4); n = 294 0.011 
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Table 1. Comparison of male and female cohort. BMI = body mass index; ODI = oxygen 
desaturation index; OSA = obstructive sleep apnoea.  
 
  
Pulse rise (h-1) 39.8 (19.9); n = 104 32.2 (17.8); n = 297 <0.001 
Mean SpO2 (%) 93.3 (2.5); n = 106 94.4 (3.9); n = 303 0.004 
Nadir SpO2 (%) 73.4 (12.0); n = 104 76.8 (9.0); n = 297 0.002 
4% ODI (h-1) 22.8 (19.9); n = 106 12.8 (15.4); n = 303 <0.001 
3% ODI (h-1) 28.5 (21.6); n = 106  17.2 (17.8); n = 303 <0.001 
<90% SpO2 (% of sleep study) 14.4 (19.5); n = 106 5.8 (10.9); n = 303 <0.001 
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Co-morbidities 
Hypertension was present in 42% (n = 171) patients, 37% (n = 153) patients had diabetes 
mellitus, 25% (n = 104) had depression, 9% (n = 37) had asthma, 7% (n = 30) had high 
cholesterol/dyslipidaemia, 7% (n = 28) had polycystic ovarian syndrome (PCOS), 5% (n = 19) 
had impaired glucose tolerance, 5% (n = 19) had anxiety, 3% (n = 13) had chronic 
obstructive pulmonary disease (COPD), 2% (n = 9) had chronic kidney disease (CKD)/renal 
impairment, 2% (n = 8) had epilepsy or a history of seizures. 
 
Medication 
25% (n = 102) were taking one (or more) oral hyperglycaemic agent(s) (metformin,  
sitagliptin, gliclazide, liraglutide), 21% (n = 87) were taking a statin (simvastatin, 
atorvastatin, rosuvastatin), 17% (n = 69) were taking one (or more) antidepressant(s) 
(escitalopram/citalopram, fluoxetine/duloxetine/paroxetine/sertraline, amitriptyline), 17% 
(n = 68) were taking a proton-pump inhibitor (omeprazole, lansoprazole), 16% (n = 64) were 
taking a calcium channel blocker (amlodipine, nifedipine, diltiazem), 15% (n = 61) were 
taking an angiotensin-converting enzyme inhibitor (“ACEi”; ramipril, lisinopril, perindopril, 
enalapril), 14% (n = 59) were taking one (or more) inhaler(s) (salbutamol, salmeterol, 
seretide, ventolin, tiotropium, symbicort, clenil modulite, beclometasone, fluticasone), 9% 
(n = 37) were taking one (or more) injected insulin(s) (Humulin, Humalog, “insulin”, 
Novomix, Novorapid), 9% (n = 37) were taking an angiotensin II receptor blocker (“ARB”; 
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losartan, irbesartan), 6% (n = 25) were taking one (or more) anti-convulsants (gabapentin, 
pregabalin, carbamezipine, valproate), 6% (n = 25) were taking orlistat. 
 
CPAP treatment 
220 (54%) patients received no further treatment, 164 (40%) patients were prescribed 
CPAP treatment and 26 (6%) patients were recommended a mandibular advancement 
device for their symptoms. Patients who required CPAP therapy were, on average, older, 
heavier, with a higher BMI and more symptomatic than patients without, as via selection, 
they had a more severe degree of OSA (Table 2). Of those on CPAP (n = 164), 125 (76%) 
were prescribed CPAP pre- and post-operatively, 17 (10%) were prescribed post-operative 
extubation onto CPAP, and 22 (13%) were referred to the Lane Fox Unit for further 
respiratory assessment of non-invasive ventilation (NIV) vs CPAP; 2 of the patients referred 
for further assessment did not require CPAP. The patients with CPAP had an average 
pressure of 13.7 (2; n = 81) cmH2O, an annual compliance of 64.0 (34.0; n = 50) %, and 
nightly use of 4.5 (1.9; n = 50) hours. The length of stay in hospital for the operated cohort 
was similar between CPAP and non-CPAP group.  
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Table 2. Comparison of patients with CPAP vs those without CPAP. LOS = length of stay; BMI 
= body mass index; ESS = Epworth Sleepiness Scale; HADS = Hospital Anxiety and Depression 
scale; ODI = oxygen desaturation index 
 
 CPAP Non-CPAP p-value 
Age (years) 49.5 (11.3); N = 155 44.9 (12.0); N = 241 <0.001 
Male VS. Female ratio 0.63:1; N = 155 0.24:1; N = 244 <0.001 
Weight (kg) 142.9 (29.8); N = 155 129.1 (24.5); N = 244 <0.001 
BMI (kg.m-2) 50.3 (8.5); N = 155 46.6 (7.7); N = 244 <0.001 
HADS (score out of 42) 16.1 (7.0); N = 10 20.5 (7.5); N = 14 0.153 
Mean heart rate (min-1) 75.8 (10.6); N = 152 71.4 (8.4); N = 239  <0.001 
pulse rise (h-1) 41.8 (20.7); N = 150 28.9 (15.0); N = 240 <0.001 
Mean SpO2 (%) 92.7 (3.8); N = 153 95.1 (3.2); N = 244 <0.001 
Nadir SpO2 (%) 69.0 (11.3) ; N = 150 80.4 (5.7) ; N = 240 <0.001 
4% ODI (h-1) 29.2 (19.7) ; N = 153 6.4 (6.5) ; N = 244 <0.001 
3% ODI (h-1) 36.4 (21.1) ; N = 153  9.5 (8.0); N = 244 <0.001 
<90% SpO2 (% of sleep 
study) 
16.5 (17.8); N = 153 2.4 (6.8); N = 244 <0.001 
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Bariatric Surgery 
During the follow up period (i.e. days since sleep study recording) of 719.4 (143; n = 53) 
days 53/413 (12.8%) patients had undergone bariatric surgery [80% female (44:9), age 48.5 
(11.4) years, 138.0 (28.5) kg, 49.3 (8.2) kg/m2]. 48 patients were class III obese, including 20 
patients who were “super obese”, and 5 patients were class I and II obese. 47% (n = 25) 
patients had hypertension, 30% (n = 16) had type 2 diabetes mellitus, 28% (n = 15) patients 
had depression, 11% (n = 6) had COPD, 9% (n = 5) had asthma. The patients had undergone 
either a laparoscopic sleeve gastrectomy (SG; n = 31), a Roux-en-Y gastric bypass (RYGB; n = 
20), and in two patients the type of surgery was not documented, with or without a 
simultaneous hernia repair. There were no patient deaths in the operated population 
during the data collection period. 
There were no significant differences between the surgical and non-surgical population 
with regards to demographics, symptom scores or nocturnal pulse oximetry data. CPAP 
treatment had been commenced in 47% (25:28) of this cohort, mean CPAP pressure was 
13.1 (2.2) cmH2O, nightly CPAP use was 4.2 (2.1) hours, and the ESS was 7.8 (5.0) points on 
treatment. The mean post-operative follow-up time was 375.3 (277.9) days. By then, 
patients had an average weight loss of 22.0% (10.5) of their body weight with no significant 
difference between the groups (Table 3). The average length of stay in hospital was 2.5 
(1.2) days, there was no difference between patients on CPAP compared to those without 
(CPAP 2.6 (1.4) vs no CPAP 2.4 (1.0) days p=0.650). 
Out of the 53 surgical patients, only 2 had any pre-, intra- or post-operative complications: 
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 A 63-year old female patient with COPD, not receiving CPAP, suffered from an acute 
kidney injury (AKI) post laparoscopic sleeve gastrectomy. This patient was treated on 
a non-ICU hospital ward for two days before being discharged; the patient has not 
had any relevant medical complications in the 9 months since their surgery.  
 A 62-year old female patient with COPD, extubated onto CPAP, suffered from 
hypercapnic (type 2) respiratory failure (HCRF) post-laparoscopic sleeve gastrectomy. 
This patient was admitted to ICU, and was treated in ICU for two days before being 
discharged. This patient has not suffered any relevant medical complications in the 4 
months since their surgery. 
 
 Surgical CPAP cohort Surgical non-CPAP cohort p-value 
Weight (kg) 139.5 (34.7); n = 25 136.7 (22.1); n = 28 0.718 
BMI (kg x m-2) 49.7 (10.4); n = 25 49.1 (5.9); n = 28 0.794 
Weight loss (%) 25.0 (10.5); n = 18 19.2 (9.8); n = 20 0.086 
 
Table 1. Comparison of pre-operative weight, BMI and weight loss following surgery in 
patients on/off CPAP. 
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Discussion 
OSA is the most common physical sleep disorder, form of sleep disordered breathing (SDB) 
and possibly also the most prevalent chronic respiratory disorder (8). OSA is compounded 
by the fact that the morbidly obese population breathe at a reduced functional residual 
capacity, approaching the residual volume, which reduces lung compliance, increases the 
physical work of breathing and minimizes the pressure gradient between the alveolar and 
intrapleural pressure (trans-pulmonary pressure) (8) necessary to drive minute ventilation 
for continuous gas exchange (6, 9). However, increased levels of neural respiratory drive in 
obesity decrease with the onset of sleep (8). In addition, basal metabolic rate and oxygen 
demand are increased, leading to a rapid decline in arterial oxygen saturation when 
breathing is interrupted (6). Increased intra-abdominal pressure creates intrinsic positive 
end-expiratory pressure, particularly in supine posture (8), and functions as a limit to the 
inspiratory load (6, 9, 16). 
 
Summary 
In a large cohort of bariatric surgery patients, sleep-disordered breathing is highly 
prevalent: 70% had some form of OSA, while 40% required peri-operative planning with 
CPAP therapy. Obese men had more severe OSA, while the majority of bariatric patients 
was female. Although only a minority of 13% had been operated during the follow up 
period, only one patient (2% of the surgical cohort), who had COPD and was extubated onto 
CPAP, suffered post-operative respiratory complications. None of the other patients had 
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any significant respiratory peri-operative complications. There was no significant difference 
in length of hospital stay between operated patients with CPAP compared to the non-CPAP 
cohort. Pre-operative established CPAP therapy and/or extubation onto CPAP proved to 
deliver the same outcomes as in the patient cohort with no or only mild OSA; CPAP therapy 
has proven to deliver an effective method of controlling respiratory complications during 
and after surgery. 
 
Clinical significance 
Previous studies have found similar results with regards to rates of OSA in bariatric surgery 
cohorts, between 73% and 78% (12, 13, 15) of bariatric surgery patients have some form of 
sleep-disordered breathing, with 24% suffering from moderate to severe OSA and 11% 
having findings suggestive of combined OSA/OHS (12).  
Sleep-disordered breathing is a significant risk factor for perioperative complications: A 
systematic review identified 8 studies linking OSA to higher rates of hypercapnic respiratory 
failure (17). Patients with moderate to severe sleep-disordered breathing are at higher risk 
of mortality, sepsis and respiratory complications after elective coronary artery bypass-
graft surgery (18). Patients with OSA and unidentified OHS had higher risks of postoperative 
respiratory failure, heart failure, prolonged intubation, and longer ICU and hospital length 
of stay than patients with nonhypercapnic OSA (19). 
Obese patients with OSA present a challenge to anaesthetists, with a significantly higher 
risk of difficult mask ventilation and laryngoscopy (20), as well as requiring more intubation 
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attempts (21). Meta-analyses have established that patients with OSA are more than twice 
as likely to suffer peri-operative respiratory complications compared to patients without 
OSA (22, 23). Many other types of surgery carry an inherently increased risk of respiratory 
complications, even in patients with no prior risk factors (11). Screening for OSA may thus 
be applicable to these types of surgery as well as bariatric surgery. 
 
Besides a difficult airway with high Mallampati score, COPD is one of the most commonly 
identifiable causes of post-operative pulmonary complications. OSA may be prevalent in 
13.8% of COPD patients and significantly compounds peri-operative risk (24). Pre-operative 
screening for OSA (and treatment with CPAP if necessary) in pre-surgical COPD patients 
may be of clinical importance. However, 23% of patients with combined COPD and OSA 
may require bilevel positive airway pressure (BiPAP) for associated hypoventilation with 
hypercapnic respiratory failure (24). Hypercapnic (type 2) respiratory failure increases 
mortality (25), particularly in patients with COPD, even in those treated on a respiratory ITU 
(26). The COPD patient who suffered from a post-operative HCRF in our cohort may 
therefore have required non-invasive ventilation instead of CPAP and as such may not 
represent a lack of efficacy in peri-operative CPAP treatment.  
 
CPAP is a routine and beneficial treatment for moderate to severe OSA (27) and has been 
recorded as an effective method of reducing peri-operative respiratory complications 
compared to patients with undiagnosed OSA without receiving CPAP (11, 28). Although 
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CPAP does reduce symptoms relating to apnoea, such as abnormalities in night-time oxygen 
levels and excessive daytime sleepiness, it has also positive effects on memory and 
cognition (29, 30), improves quality of life, reduces blood pressure (31) and improves 
cardiac outcomes (32). However, despite patients experiencing relief of sleep-related 
symptoms, compliance to CPAP treatment remains suboptimal, with as many as half of the 
patients not sufficiently adhering to treatment at one year (17). Indeed, our study found 
that patients only used their prescribed CPAP during two out of every three nights, on 
average. 
The similar length of stay between the groups with and without OSA highlights the 
effectiveness of CPAP – patients prescribed appropriate CPAP had outcomes and hospital 
stays comparable to patients who did not require it at all. This demonstrates that CPAP is 
effective in managing the respiratory needs of bariatric patients and those with obstructive 
sleep apnoea. 
The Epworth Sleepiness Scale (ESS) is the most commonly used questionnaire in sleep 
medicine (13), but it does not differentiate between various causes of excessive daytime 
sleepiness (EDS) (33), or correlate with objective measures of EDS (9) and its applicability to 
obese patients is controversial (34). For these reasons, the STOP-BANG questionnaire has 
taken precedence for OSA screening in obese patients in the pre-operative clinics (20). The 
STOP-BANG questionnaire is based on snoring, daytime tiredness, observed apnoeic 
episodes, BMI over 35 kg/m2, advanced age, male gender, a history of hypertension and 
neck circumference (35). These criteria are highly sensitive (94-96%) in the diagnosis of 
moderate-severe OSA (36). 
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Limitations 
Patients studied were selected solely based on high-risk STOP-BANG scores, thus patients 
with lower scores were not followed. Future research should attempt to include all surgical 
patients to determine the presence (or absence) of any peri-operative respiratory 
complications in those not screened via the sleep service. Additionally, although highly 
sensitive, the STOP-BANG score is not a measure of OSA, and patients with actual OSA may 
not have a high STOP-BANG score, excluding them from the cohort despite their suitability 
for treatment. 
Furthermore, all patients with moderate-severe OSA were treated with CPAP, and we 
cannot claim that there was an increased risk of complications if these patients had 
remained untreated. However, the fact that overall risks were low and comparable 
between groups is reassuring in that the proposed management plan is sufficient. In the 
context of a randomised controlled clinical trial, the use of sham-CPAP, an effective placebo 
for CPAP (37), if ethically acceptable, would provide more evidence about the effectiveness 
of peri-operative CPAP. Hip circumference measurements would have been of interest for 
assessing insulin resistance. HAD scores for surgical patients would have also been useful to 
assess the psychological profile of this cohort. However, the surgical cohort matched the 
non-surgery cohort, and it is therefore likely that the HAD scores could be assumed to be 
similar. Additionally, although CPAP is effective in OSA, BiPAP may be more suitable for 
patients with combined OSA and COPD. 
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Lastly, this study focused on peri-operative outcomes in bariatric/abdominal surgery, but 
pre-operative OSA screening and subsequent CPAP treatment may be applicable to other 
forms of (respiratory) high-risk surgery as well.  
 
Conclusion 
Bariatric patients screened pre-operatively for OSA and treated with CPAP, according to 
guidelines, suffer few respiratory complications. Pre-operative screening for OSA and peri-
operative treatment with CPAP in morbidly obese patients is an effective method of 
reducing respiratory disease-related morbidity and mortality in the bariatric population.  
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